Stay updated on Tisotumab Vedotin in Cervical Cancer Clinical Trial

Sign up to get notified when there's something new on the Tisotumab Vedotin in Cervical Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tisotumab Vedotin in Cervical Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision metadata updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T20:21:56.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, and the funding/status notice as well as Revision: v3.4.1 were removed. These are site maintenance updates that do not alter the study details or data.
    Difference
    0.3%
    Check dated 2026-02-11T02:33:12.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide notice about a funding lapse and the NIH Clinical Center opening status has been added, and the site revision updated to v3.4.1 (replacing v3.4.0).
    Difference
    0.3%
    Check dated 2026-02-04T01:35:28.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI and metadata updates: a glossary toggle is now shown, and QC/FEAR Act data labels have been added or adjusted. The document revision tag has been updated to v3.4.0.
    Difference
    0.1%
    Check dated 2026-01-28T00:17:42.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page. There are no changes to study content, eligibility criteria, or data.
    Difference
    0.0%
    Check dated 2026-01-14T01:15:28.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a comprehensive Locations section listing site locations (Alabama, Arizona, California, Florida, Georgia, Indiana, Kentucky, Massachusetts, Nevada, New Jersey, New Mexico, Ohio, Oklahoma, Pennsylvania, South Carolina, Texas, Wisconsin) and updated page revision to v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T09:17:16.000Z thumbnail image

Stay in the know with updates to Tisotumab Vedotin in Cervical Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tisotumab Vedotin in Cervical Cancer Clinical Trial page.